Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Other authors

Institut Català de la Salut

[Vinci L, Noellke P, Lebrecht D] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Flotho C] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Heidelberg and Freiburg, Freiburg, Germany. [Masetti R] Pediatric Oncology and Hematology, IRCCS Azienda OspedalieroUniversitaria di Bologna, Bologna, Italy. [de Haas V] Princess Maxima Center, Diagnostic Laboratory/DCOG Laboratory, Utrecht, The Netherlands. [Diaz de Heredia C] Unitat de Trasplantament de Progenitors Hematopoètics, Servei d'Hematologia i Oncologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-06-23T11:12:42Z

2023-06-23T11:12:42Z

2023-05



Abstract

Myeloproliferative disease; Paediatrics


Enfermedad mieloproliferativa; Pediatría


Malaltia mieloproliferativa; Pediatria


Open Access funding enabled and organized by Projekt DEAL.

Document Type

Article


Published version

Language

English

Publisher

Springer Nature

Related items

Bone Marrow Transplantation;58

https://doi.org/10.1038/s41409-023-01942-4

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)